ARTICLE | Clinical News
Peramivir regulatory update
January 18, 2010 8:00 AM UTC
BioCryst said partner Green Cross submitted an NDA in South Korea for IV peramivir to treat influenza. Green Cross has South Korean rights to the injectable formulation of viral neuraminidase inhibit...